Astria Therapeutics, Inc. Deferred Revenue (Non-Current)
Astria Therapeutics, Inc. had Deferred Revenue (Non-Current) of $12.04 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2025-11-12
- 2025-09-30: Deferred Revenue, Noncurrent $12.04M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2025-09-30 | $12.04M 10-Q · filed 2025-11-12 |